NVISION Laser Eye Centers announced the availability of LipiFlow evaporative dry eye treatment at its 17 California locations.
Ophthalmology
Eye Institute of Utah in Salt Lake City and New York Eye and Ear Infirmary have acquired Sony Electronics' end-to-end 3-D imaging solution for ophthalmic surgery.
The Accreditation Association for Ambulatory Healthcare has conducted a series of clinical studies on cataract extraction surgeries with lens insertion, the most common outpatient surgical procedure, and released nine patient outcome statistics.
Nearly 400 members of the American Academy of Ophthalmologists have gathered at Capitol Hill today to protest Medicare Cuts, arguing such cuts will be harmful to the ophthalmic care of seniors.
The Bausch + Lomb Trulign toric accommodating posterior chamber ocular lens has received premarket approval from the Ophthalmic Devices Panel of the FDA, according to a Medscape report.
Researchers of The Schepens Eye Research Institute of Massachusetts Eye and Ear in Boston and the Harvard Medical School ophthalmology department have conducted a study that shows Ranibizumab as a promising prevention of proliferative vitreoretinopathy.
Bausch + Lomb's VICTUS Femtosecond laser platform has received CE Mark for corneal incisions made during cataract surgery, according to a Laser Focus World report.
NovaBay Pharmaceuticals, an Emeryville, Calif.-based biotechnology company, has enrolled its first patients in a global Phase 2b clinical trial designed to test its Auriclosene Ophthalmic Solution as a treatment for a highly contagious form of pink-eye.
The FDA has granted Bausch + Lomb approval for PROLENSA, its anti-inflammatory prescription eye drop for patients that have undergone cataract surgery.
Aiello Eye Institute in Yuma, Ariz., has announced that it has added optical services to the LASIK, cataract surgery and various ophthalmology options offered at its Foothills location.
